...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: China Deal for Zenith?

Sanfran, does this not also suggest a quick and high probability of success of the approval of the BETonMACE phase 3 trial for rvx-208 since it is an epigenetic drug? I would think so. There should be announcements soon IMHO.

Cheers

Toinv

Share
New Message
Please login to post a reply